Thu, August 19, 2021
Wed, August 18, 2021
Tue, August 17, 2021
Mon, August 16, 2021
Sun, August 15, 2021
Fri, August 13, 2021
Thu, August 12, 2021
Wed, August 11, 2021
Tue, August 10, 2021

Matthew Harrison Maintained (SRPT) at Hold with Decreased Target to $90 on, Aug 16th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-90-on-aug-16th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Hold with Decreased Target from $93 to $90 on, Aug 16th, 2021.

Matthew has made no other calls on SRPT in the last 4 months.



There are 4 other peers that have a rating on SRPT. Out of the 4 peers that are also analyzing SRPT, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Anupam Rama of "JP Morgan" Upgraded from Sell to Hold and Decreased Target to $87 on, Thursday, August 5th, 2021
  • Judah Frommer of "Credit Suisse" Maintained at Hold with Increased Target to $75 on, Thursday, August 5th, 2021


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Decreased Target to $122 on, Thursday, August 5th, 2021
  • Yun Zhong of "BTIG" Initiated at Strong Buy and Held Target at $110 on, Tuesday, June 15th, 2021

Publication Contributing Sources